GLP-1 drugs have benefits beyond weight loss. Could microdoses preserve them?
A narrative review suggests GLP-1-based therapies deliver metabolic, cardiovascular, renal, and other systemic benefits, raising interest in whether lower fractional doses could improve tolerability and treatment continuity. However, direct evidence…